January 22, 2018 by Chain Drug Review
Alex Gourlay, Dixons Carphone, Elizabeth Fagan, Sebastian James, Walgreens Boots Alliance
Business, Leading Headlines, Retail News
DEERFIELD, Ill. — Sebastian James is joining Walgreens Boots Alliance (WBA) as senior vice president and as president and managing director of Boots, the company’s international pharmacy, health and beauty chain based in the United Kingdom. Plans call for James, currently group chief executive at European electronics and telecom retailer and service provider Dixons Carphone plc, to join
January 17, 2018 by Geoff Walden
James Skinner, Stefano Pessina, Walgreens, Walgreens Boots Alliance, Walgreens Boots Alliance annual shareholders meeting
Business, Leading Headlines, Retail News
SCOTTSDALE, Ariz. — Walgreens is halfway through a transformation that includes a rethinking of its supply chain and services, Walgreens Boots Alliance executive vice chairman and CEO Stefano Pessina said at the company’s annual shareholders meeting. Walgreens is also recasting its approach to interacting with customers and patients, Pessina added, noting that 2018 will see
January 17, 2018 by Chain Drug Review
2018 Retail Forecast, Albertsons, Alex Gourlay, AmerisourceBergen, Brian Nightengale, Cardinal Health, Care Pharmacies, Carmen Churcott, Chris Dimos, CVS Health, Discount Drug Mart, Fruth Pharmacy, Genoa, Good Neighbor Pharmacy, Hy-Vee, Jeff Leger, John Figueroa, John Standley, Kristin Williams, Larry Merlo, Lynne Fruth, Mark Panzer, McKesson, Medicine Shoppe, Michael Wysong, Mike Eby, Pharmaca, Pharmasave, Richard Willis, Rite Aid, Robert Mauch, Shoppers Drug Mart, Steve Lawrence, Todd Treon, Walgreens Boots Alliance
Featured Articles, Leading Headlines, Pharmacy, Retail News
What will the second year of the Trump administration look like? Is the demise of the Affordable Care Act imminent? Will pharmacists get the greater role in health care they have long sought? These are among the questions top chain drug industry executives are pondering as they look to 2018. With spiraling health care costs and
January 15, 2018 by Chain Drug Review
EnvisionRx, Health Dialog, Kermit Crawford, RediClinic, Rite Aid, Walgreens Boots Alliance
2018, Issue 01-15-2018, Issues, News
CAMP HILL, Pa. — Rite Aid Corp. president and chief operating officer Kermit Crawford said he’s confident the company “will succeed in building the new Rite Aid” following its $4.375 billion asset sale to Walgreens Boots Alliance (WBA). Under the deal, announced in September, Rite Aid is selling 1,932 stores, three distribution centers and related
January 4, 2018 by Chain Drug Review
Rite Aid, Stefano Pessina, Walgreens Boots Alliance
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Strong sales gains by the U.S. retail pharmacy division propelled Walgreens Boots Alliance (WBA) in its fiscal 2018 first quarter, which also saw the company exceed Wall Street’s earnings forecast. WBA said Thursday that, for the quarter ended Nov. 30, sales totaled $30.74 billion, up 7.9% from $28.5 billion a year earlier.
January 3, 2018 by Chain Drug Review
John Standley, Rite Aid, Walgreens Boots Alliance
Business, Leading Headlines, Retail News
CAMP HILL, Pa. — Rite Aid Corp. topped Wall Street’s earnings projections for its fiscal 2018 third quarter, in which the company proceeded with the transfer of stores under its $4.375 billion asset sale to Walgreens Boots Alliance (WBA). Rite Aid said late Wednesday that for the quarter ended Dec. 2, net income totaled $81
January 2, 2018 by Jeffrey Woldt and Chain Drug Review
Alex Gourlay, Chain Drug Review, Ornella Barra, Retailer of the Year, Retailer of the Year Award, Rite Aid, Walgreens, Walgreens Boots Alliance, WBA
2018, Featured Articles, Issue 01-01-2018, Issues, Leading Headlines, News, Retail News
DEERFIELD, Ill. — To the casual observer, the dominant story line at Walgreens might appear to be the phased acquisition of 1,932 drug stores and related assets from Rite Aid Corp., and plans for their subsequent assimilation. But, important as the deal is, it shouldn’t be allowed to obscure other compelling developments at Walgreens Boots
January 1, 2018 by Jeffrey Woldt and Chain Drug Review
Aetna, Affordable Care Act, CVS Health, CVS-Aetna merger, Jeffrey Woldt, Larry Merlo, Matthew Shay, National Retail Federation, Rite Aid, Tax Cuts and Jobs Act, Walgreens Boots Alliance
2018, Issue 01-01-2018, Issues, Opinion
A case could be made that for pharmacy operators passage of the Tax Cuts and Jobs Act late last month was the biggest story of 2017. Championed by the Republican leadership in Congress and President Trump, the $1.5 trillion measure will provide substantial, permanent tax relief for businesses — the corporate tax rate was cut
December 14, 2017 by CDR Blog and Chain Drug Review
Amazon, Brian Tanquilut, CVS-Aetna merger, FedEx, Jefferies, Walgreens Boots Alliance
CDR Blog
A CVS-Aetna merger or not, Walgreens Boots Alliance is zeroed in and making headway on its strategic game plan, according to Jefferies analyst Brian Tanquilut. Following a visit to WBA’s headquarters in Deerfield, Ill., last week by the Jefferies team, Tanquilut reported that the CVS deal didn’t “prompt a kneejerk reaction,” and WBA executives remain
December 7, 2017 by Chain Drug Review
Alex Gourlay, Gregory Weishar, Jim Momtazee, KKR, Kohlberg Kravis Roberts, PharMerica, Walgreens Boots Alliance
Business, Leading Headlines, Pharmacy, Retail News
LOUISVILLE, Ky. — Walgreens Boots Alliance (WBA) is now a stakeholder in national specialty pharmacy operator PharMerica Corp. PharMerica on Wednesday announced the close of its acquisition by global investment firm Kohlberg Kravis Roberts (KKR). Under the $1.4 billion deal, unveiled in early August, WBA holds a minority share in PharMerica. Louisville, Ky.-based PharMerica serves
December 4, 2017 by Chain Drug Review
GuoDa, GuoDa Drug Store, Sinopharm Holding GuoDa Drug Store Co., Stefano Pessina, Walgreens Boots Alliance
Business, Issue 12-11-2017, Leading Headlines, News, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) plans to pay about $416 million to acquire a 40% stake in Sinopharm Holding GuoDa Drug Store Co. WBA confirmed the deal on Monday. GuoDa is the largest retail pharmacy operator in China, with nearly 3,700 stores. With stores in 70 major cities across the country, GuoDa is
December 1, 2017 by Bill Schiffner
Adam Holyk, Alex Gourlay, At the Corner of Happy and Healthy, Charles R. Walgreen Sr., new Walgreens branding campaign, Trusted since 1901, Walgreens, Walgreens Boots Alliance
Business, Featured Articles, Issue 12-11-2017, Leading Headlines, News, Retail News
DEERFIELD, Ill. — As part of a brand repositioning, Walgreens is changing its tagline to “Trusted Since 1901” to emphasize its long heritage of serving customers. Walgreens said Friday that the new slogan, which will replace “At the Corner of Happy and Healthy,” will make its debut in a 30-second television commercial that will air
November 28, 2017 by Chain Drug Review
John Standley, Rite Aid, Walgreens Boots Alliance, Walgreens-Rite Aid merger deal
Business, Featured Articles, Leading Headlines, Retail News
CAMP HILL, Pa. — Walgreens Boots Alliance (WBA) has taken over the first group of Rite Aid stores as part of the asset sale agreement the companies unveiled in September. Rite Aid Corp. said late Monday that it has transferred 97 stores and related assets to WBA. This completes the pilot closing and first subsequent
November 20, 2017 by Chain Drug Review
Alex Gourlay, Richard Ashworth, Walgreens, Walgreens Boots Alliance
2017, Issue 11-20-2017, Issues, News
DEERFIELD, Ill. — Walgreens Boots Alliance Inc. (WBA) has promoted Richard Ashworth to president of operations at Walgreens, a newly created position. With the move, Ashworth adds responsibilities in the health care commercial, IT and supply chain areas at Walgreens in addition to the duties in his previous position as president of pharmacy and retail